Max Healthcare Institute share price closes at ₹1,056.50; falls 0.95% on September 22
Last Updated: 22nd September 2026 - 06:51 pm
Key Takeaways
- Max Healthcare Institute declined ₹10.10 or 0.95% to ₹1,056.50 after moving within a ₹19 session range.
- The closing price remained above all three displayed moving averages, including the 200-day DMA of ₹1,052.50 by ₹4.
- One-month and six-month returns were positive, while three-month and one-year performance remained negative.
Max Healthcare Institute share price closed September 22 at ₹1,056.50, down ₹10.10 or 0.95% from the previous close of ₹1,067. The stock opened at ₹1,060 and advanced to ₹1,069. It later reached ₹1,050 before finishing ₹6.50 above the low.
The day's high-low range was ₹19. Max Healthcare ended ₹12.50 below the high and only ₹3.50 below its opening level. Trading volume was 1,318,097 shares. Market capitalisation stood at approximately ₹102,830 crore.
Despite the daily decline, the closing price remained above all three moving averages displayed on the page. The 50-day DMA was ₹1,037.20, leaving the close ₹19.30 higher. The 100-day DMA stood at ₹1,042.50, a ₹14 difference. The 200-day DMA was ₹1,052.50, only ₹4 below the September 22 finish.
The 52-week range extended from ₹903 to ₹1,222. At ₹1,056.50, Max Healthcare was ₹153.50 above the annual low and ₹165.50 below the high, placing it close to the midpoint of that broader range.
Return figures changed direction across the four periods. The one-month return was positive at 5.65%. Three-month performance was -3.49%, while the six-month return stood at 9.50%. The one-year reading was -8.90%. September 22 itself ended 0.95% lower, but the stock still finished slightly above the 200-day DMA and more clearly above its 50-day and 100-day averages.
Frequently Asked Questions
Was Max Healthcare above its 200-day DMA?
What was Max Healthcare's daily range?
What were Max Healthcare's recent returns?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.